• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将多种风险因素结合作为一种筛查测试的效果。

The efficacy of combining several risk factors as a screening test.

作者信息

Wald Nicholas J, Morris Joan K, Rish Simon

机构信息

Wolfson Institute of Preventive Medicine, Barts and the London Queen Mary's School of Medicine and Dentistry, Charterhouse Square, London EC1 M 6BQ, UK.

出版信息

J Med Screen. 2005;12(4):197-201. doi: 10.1258/096914105775220642.

DOI:10.1258/096914105775220642
PMID:16417697
Abstract

OBJECTIVE

To determine the quantitative effect on overall screening performance (detection rate for a given false-positive rate) of using several moderately strong, independent risk factors in combination as screening markers.

SETTING

Theoretical statistical analysis.

METHODS

For the purposes of this analysis, it was assumed that all risk factors were independent, had Gaussian distributions with the same standard deviation in affected and unaffected individuals and had the same screening performance. We determined the overall screening performance associated with using an increasing number of risk factors together, with each risk factor having a detection rate of 10%, 15% or 20% for a 5% false-positive rate. The overall screening performance was estimated as the detection rate for a 5% false-positive rate.

RESULTS

Combining the risk factors increased the screening performance, but the gain in detection at a constant false-positive rate was relatively modest and diminished with the addition of each risk factor. Combining three risk factors, each with a 15% detection rate for a 5% false-positive rate, yields a 28% detection rate. Combining five risk factors increases the detection rate to 39%. If the individual risk factors have a detection rate of 10% for a 5% false-positive rate, it would require combining about 15 such risk factors to achieve a comparable overall detection rate (41%).

CONCLUSION

It is intuitively thought that combining moderately strong risk factors can substantially improve screening performance. For example, most cardiovascular risk factors that may be used in screening for ischaemic heart disease events, such as serum cholesterol and blood pressure, have a relatively modest screening performance (about 15% detection rate for a 5% false-positive rate). It would require the combination of about 15 or 20 such risk factors to achieve detection rates of about 80% for a 5% false-positive rate. This is impractical, given the risk factors so far discovered, because there are too few risk factors and their associations with disease are too weak.

摘要

目的

确定联合使用多个中等强度的独立风险因素作为筛查标志物对整体筛查性能(给定假阳性率下的检测率)的定量影响。

设置

理论统计分析。

方法

为进行该分析,假设所有风险因素相互独立,在患病和未患病个体中具有相同标准差的高斯分布,且具有相同的筛查性能。我们确定了联合使用越来越多风险因素时的整体筛查性能,每个风险因素在5%假阳性率下的检测率为10%、15%或20%。整体筛查性能以5%假阳性率下的检测率来估计。

结果

联合风险因素可提高筛查性能,但在恒定假阳性率下检测率的增加相对较小,且随着每个风险因素的增加而减弱。联合三个风险因素,每个因素在5%假阳性率下的检测率为15%,则检测率为28%。联合五个风险因素可将检测率提高到39%。如果个体风险因素在5%假阳性率下的检测率为10%,则需要联合约15个这样的风险因素才能达到相当的整体检测率(41%)。

结论

直观地认为,联合中等强度的风险因素可显著提高筛查性能。例如,大多数可用于筛查缺血性心脏病事件的心血管风险因素,如血清胆固醇和血压,筛查性能相对较低(5%假阳性率下约15%的检测率)。要在5%假阳性率下达到约80%的检测率,需要联合约15或20个这样的风险因素。鉴于目前已发现的风险因素,这是不切实际的,因为风险因素太少且它们与疾病的关联太弱。

相似文献

1
The efficacy of combining several risk factors as a screening test.将多种风险因素结合作为一种筛查测试的效果。
J Med Screen. 2005;12(4):197-201. doi: 10.1258/096914105775220642.
2
Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.唐氏综合征的偶然筛查是一种有效的替代不透露顺序筛查的方法。
Prenat Diagn. 2004 Oct;24(10):762-6. doi: 10.1002/pd.974.
3
The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy.在孕早期使用母体血清生化指标和胎儿颈部透明带厚度筛查染色体异常时校正吸烟状态的影响。
Prenat Diagn. 2004 Mar;24(3):169-73. doi: 10.1002/pd.819.
4
The effect of correlations between screening markers on screening performance.筛查标志物之间的相关性对筛查性能的影响。
J Med Screen. 2007;14(3):151-7. doi: 10.1258/096914107782066149.
5
The impact of bias in MoM values on patient risk and screening performance for Down syndrome.中位数倍数(MoM)值中的偏倚对唐氏综合征患者风险及筛查性能的影响。
Prenat Diagn. 2007 Sep;27(9):840-5. doi: 10.1002/pd.1791.
6
Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.既往妊娠中标记物水平校正对唐氏综合征筛查性能的影响。
Prenat Diagn. 2006 Jun;26(6):539-44. doi: 10.1002/pd.1455.
7
Graphical presentation of distributions of risk in screening.筛查中风险分布的图形展示。
J Med Screen. 2005;12(3):155-60. doi: 10.1258/0969141054855283.
8
Contingent screening for Down syndrome--results from the FaSTER trial.唐氏综合征的应急筛查——来自FaSTER试验的结果。
Prenat Diagn. 2008 Feb;28(2):89-94. doi: 10.1002/pd.1913.
9
Combining first and second trimester markers for Down syndrome screening: think twice.结合孕早期和孕中期指标进行唐氏综合征筛查:三思而后行。
Aust N Z J Obstet Gynaecol. 2008 Oct;48(5):492-500. doi: 10.1111/j.1479-828X.2008.00911.x.
10
Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.比较三种用于联合孕早期和孕中期唐氏综合征标志物的筛查策略。
Obstet Gynecol. 2006 Feb;107(2 Pt 1):367-75. doi: 10.1097/01.AOG.0000195061.48747.f4.

引用本文的文献

1
Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies.血液基因表达风险谱与间质性肺异常:COPDGene 和 ECLIPSE 队列研究。
Respir Res. 2022 Jun 17;23(1):157. doi: 10.1186/s12931-022-02077-8.
2
Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.慢性阻塞性肺疾病及相关表型:基于人群和病例对照队列的多基因风险评分。
Lancet Respir Med. 2020 Jul;8(7):696-708. doi: 10.1016/S2213-2600(20)30101-6.
3
Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle-Aged, Apparently Healthy Population.
基于示波法的主动脉脉搏波速度可在中年健康人群中检测出无症状颈动脉粥样硬化。
Biomed Res Int. 2020 Jan 16;2020:8571062. doi: 10.1155/2020/8571062. eCollection 2020.
4
The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease.公共卫生领域中平均值的暴政以及风险因素的滥用:以冠心病为例。
SSM Popul Health. 2017 Aug 18;3:684-698. doi: 10.1016/j.ssmph.2017.08.005. eCollection 2017 Dec.
5
Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.评估虹膜颜色和生育子女对诊断为葡萄膜黑色素瘤后 5 年死亡风险的影响:一项随访研究。
BMC Ophthalmol. 2014 Apr 1;14:42. doi: 10.1186/1471-2415-14-42.
6
Role of C-reactive protein when prescribing a statin.当开具他汀类药物时 C-反应蛋白的作用。
Curr Atheroscler Rep. 2012 Feb;14(1):26-32. doi: 10.1007/s11883-011-0218-8.
7
The SHAPE guideline: ahead of its time or just in time?SHAPE 指南:领先时代还是恰逢其时?
Curr Atheroscler Rep. 2011 Oct;13(5):345-52. doi: 10.1007/s11883-011-0195-y.
8
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.高危斑块倡议:无症状人群的动脉粥样硬化血栓形成事件的一级预防。
Curr Atheroscler Rep. 2011 Oct;13(5):359-66. doi: 10.1007/s11883-011-0193-0.
9
Screening for future cardiovascular disease using age alone compared with multiple risk factors and age.仅使用年龄与多种危险因素和年龄相比,对未来心血管疾病进行筛查。
PLoS One. 2011 May 4;6(5):e18742. doi: 10.1371/journal.pone.0018742.
10
Utility of genetic determinants of lipids and cardiovascular events in assessing risk.血脂和心血管事件遗传决定因素在风险评估中的作用。
Nat Rev Cardiol. 2011 Apr;8(4):207-21. doi: 10.1038/nrcardio.2011.6. Epub 2011 Feb 15.